Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Rapid response of aggressive cranial Langerhans cell histiocytosis to combined intralesional and perilesional triamcinolone injection: a case report with video.

Created on 17 Jul 2026

Authors

Jesús A Sánchez Hernández, Mónica Rivero Garvia, Gloria Moreno Madueño, José I Gutiérrez Carrasco, Javier Márquez Rivas

Published in

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery. Volume 42. Issue 1. Jul 16, 2026. Epub Jul 16, 2026.

Abstract

Langerhans cell histiocytosis (LCH) is a rare myeloid neoplasm that predominantly affects bone in the pediatric population, with the skull being one of the most frequent sites of involvement. Local complications following diagnostic procedures in this context are exceptionally rare and poorly described. We report the case of a 14-year-old male with unifocal cranial LCH who developed aggressive local progression after a diagnostic biopsy, characterized by progressive bone destruction, soft tissue involvement, surgical wound dehiscence, and exposure of tumor tissue. Given the rapid evolution of the lesion and the limitations for conventional surgical management, intralesional and perilesional triamcinolone infiltration (40 mg) was performed. A prompt clinical response was observed, with a significant reduction in lesion volume within 4 days. Follow-up magnetic resonance imaging at that time demonstrated a 50-70% decrease in the soft tissue component. During subsequent follow-up, progressive skin healing and early signs of bone repair were noted. This case highlights an uncommon local complication following biopsy of pediatric cranial LCH and suggests that local corticosteroid infiltration may represent a minimally invasive and potentially useful therapeutic alternative in selected cases with aggressive local progression and limited surgical options.

PMID:
42463551
Bibliographic data and abstract were imported from PubMed on 17 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 3
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement